tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Ascentage Pharma Updates on Proposed U.S. IPO Plans
Company AnnouncementsAscentage Pharma Updates on Proposed U.S. IPO Plans
2d ago
6855
Ascentage Pharma Appoints Esteemed Oncologist to Board
PremiumCompany Announcements
Ascentage Pharma Appoints Esteemed Oncologist to Board
21d ago
6855
Ascentage Pharma Unveils Diverse Board Leadership
PremiumCompany Announcements
Ascentage Pharma Unveils Diverse Board Leadership
21d ago
6855
Ascentage Pharma Moves Toward Nasdaq IPO
PremiumCompany Announcements
Ascentage Pharma Moves Toward Nasdaq IPO
25d ago
6855
Ascentage Pharma’s Olverembatinib Joins China’s Reimbursement List
PremiumCompany Announcements
Ascentage Pharma’s Olverembatinib Joins China’s Reimbursement List
2M ago
6855
Ascentage Pharma Enhances Board with Strategic Appointments
PremiumCompany AnnouncementsAscentage Pharma Enhances Board with Strategic Appointments
2M ago
6855
Ascentage Pharma Announces Board Roles and Structure
Premium
Company Announcements
Ascentage Pharma Announces Board Roles and Structure
2M ago
6855
Ascentage Pharma’s Lisaftoclax Advances in Drug Approval
Premium
Company Announcements
Ascentage Pharma’s Lisaftoclax Advances in Drug Approval
2M ago
6855
Ascentage Pharma Showcases Promising Drug Developments
PremiumCompany Announcements
Ascentage Pharma Showcases Promising Drug Developments
3M ago
6855
Ascentage Pharma Adjusts RSU Schemes for Strategic Gains
PremiumCompany Announcements
Ascentage Pharma Adjusts RSU Schemes for Strategic Gains
3M ago
6855
Ascentage Pharma’s APG-2449 Advances to Phase III
PremiumCompany Announcements
Ascentage Pharma’s APG-2449 Advances to Phase III
4M ago
6855
Ascentage Pharma Issues New Employee RSUs
PremiumCompany Announcements
Ascentage Pharma Issues New Employee RSUs
5M ago
6855
Ascentage Pharma Reports Soaring H1 2024 Revenue
PremiumCompany AnnouncementsAscentage Pharma Reports Soaring H1 2024 Revenue
5M ago
6855
Ascentage Pharma Schedules Crucial Financial Review
Premium
Company Announcements
Ascentage Pharma Schedules Crucial Financial Review
6M ago
6855
Ascentage Pharma Completes New Share Issuance
Premium
Company Announcements
Ascentage Pharma Completes New Share Issuance
7M ago
6855
Ascentage Pharma Reports Promising Clinical Outcomes
PremiumCompany Announcements
Ascentage Pharma Reports Promising Clinical Outcomes
7M ago
6855
Ascentage Pharma’s New Share Issuance Deal
PremiumCompany Announcements
Ascentage Pharma’s New Share Issuance Deal
7M ago
6855
Ascentage Pharma Inks Major Licensing Deal
PremiumCompany Announcements
Ascentage Pharma Inks Major Licensing Deal
7M ago
6855
Ascentage Pharma Plans Confidential IPO Filing
PremiumCompany Announcements
Ascentage Pharma Plans Confidential IPO Filing
7M ago
6855
Ascentage Pharma Announces Director Resignation and Board Changes
PremiumCompany AnnouncementsAscentage Pharma Announces Director Resignation and Board Changes
8M ago
6855
Ascentage Pharma Announces Board Structure
Premium
Company Announcements
Ascentage Pharma Announces Board Structure
8M ago
6855
Ascentage Pharma Showcases Drug Advances at ASCO 2024
Premium
Company Announcements
Ascentage Pharma Showcases Drug Advances at ASCO 2024
8M ago
6855

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >